14% body weight regained within one year of stopping tirzepatide 14% body weight regained within one year of stopping tirzepatide Other reputable clinical studies have been consistent in finding that patients experience significant weight regain* when they discontinue these medications.* The drawbacks of a one-size-fits-all approach Programs that promote GLP-1 deprescribing often employ a one-size-fits-all strategy including the diet used as a part of their program
The Lancet Diabetes & Endocrinology, 5 (9), 739749
These products are often advertised and sold online, through social media, or at certain med-spas
Furthermore, when combined with healthy dietary patterns or lifestyle interventions like intermittent fasting, exercise may produce synergistic effects, offering a more comprehensive strategy for prevention and management of atherosclerosis
The issue has become increasingly relevant as many people prepare for summer and turn to weight loss medication to boost confidence and improve long term health
This symptom overlap could potentially complicate the clinical picture and make it challenging to distinguish medication side effects from celiac disease activity